Latest filing published 04 Sept 2014 for AVIENT CORP, €5.7M.
Insider track record
No signal scores available.
Closed purchases
Based on 9 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -79.0%Entry US$6.82 · Close at T+365 US$1.43
- -73.8%Entry US$6.91 · Close at T+365 US$1.81
- -50.5%Entry US$6.26 · Close at T+365 US$3.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Thomas J. Kedrowski: trading record in brief
Thomas J. Kedrowski discloses dealings in Avient Corp to SEC (Form 4). Between 15 November 2007 and 2 September 2014, the trades on record add up to 41 filings.
Market trades split into 9 purchases (€329k) and 1 sale (€5.7M). Taken together, the sales exceed the purchases by €5.3M. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Outside the open market, there are 5 share grants and 15 option exercises. Since January 2014: no purchases and 1 sale on the market.
In size, the median ticket on the buying side is €12k. For 9 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 100% of cases, with a median move of +7.0%. Past outcomes like these are no guarantee of what comes next.
The record was last updated on 4 September 2014 with an open-market sale (€5.7M) in Avient Corp. The last purchase on record was published on 3 March 2008, which is 6,825 days ago. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 3 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Thomas J. Kedrowski
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 189,999.76 shares@ US$39.21Common StockSEC:0001534158-14-000151:0
- 5,367 shares@ US$14.81Common StockSEC:0001534158-14-000119:0
- 3,375 shares@ US$42.13Common StockSEC:0001534158-14-000119:1
- 7,766 shares@ US$14.61Common StockSEC:0001534158-14-000119:2
- 5,075 shares@ US$42.13Common StockSEC:0001534158-14-000119:3
- 4,967 shares@ US$23.08Common StockSEC:0001534158-14-000119:4
- 3,776 shares@ US$42.13Common StockSEC:0001534158-14-000119:5
- 8,900 sharesCommon StockSEC:0001534158-14-000057:0
- 3,034 shares@ US$36.04Common StockSEC:0001534158-14-000057:1
- 5,366 shares@ US$14.81Common StockSEC:0001571314-13-000027:2
- 3,888 shares@ US$24.98Common StockSEC:0001571314-13-000027:3
- 7,767 shares@ US$14.61Common StockSEC:0001571314-13-000027:4
- 5,586 shares@ US$24.98Common StockSEC:0001571314-13-000027:5
- 13,500 sharesCommon StockSEC:0001534158-13-000038:0
- 4,557 shares@ US$23.08Common StockSEC:0001534158-13-000038:1
- 60,000 shares@ US$7.68Common StockSEC:0001534158-12-000164:0
- 41,462 shares@ US$15.97Common StockSEC:0001534158-12-000164:1
- 31,200 shares@ US$6.77Common StockSEC:0001534158-12-000164:2
- 20,671 shares@ US$15.97Common StockSEC:0001534158-12-000164:3
- 48,000 shares@ US$1.43Common StockSEC:0001534158-12-000164:4
- 22,423 shares@ US$15.90Common StockSEC:0001534158-12-000164:5
- 16,133 shares@ US$7.99Common StockSEC:0001534158-12-000164:6
- 11,434 shares@ US$151.90Common StockSEC:0001534158-12-000164:7
- 5,367 shares@ US$14.81Common StockSEC:0001534158-12-000164:8
- 5,152 shares@ US$15.90Common StockSEC:0001534158-12-000164:9
25 of 36 declarations
